ORIENT BIO financial statements
오리엔트바이오KRX:002630 · KOSPI · Healthcare₩1,640+0.74%
2026-10-02 closeORIENT BIO's published financial data is dated 2026-10-04. 2025 revenue was KRW 29.4B. 2025 operating profit was −KRW 3.08B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy